Medexprim is proud to be the only French startup, as well as the only European Real-World Data and Real-World Evidence company, to have been selected by Euroquity for the Access2EIC – Seal of Excellence e-Pitch session held last November 24, as one of the « best eight European companies that have recently received a Seal of Excellence certificate » from the European Commission.

Read more about the selection from more than a hundred Seal of Excellence holders here.

Thank you to Gilles Le Cocguen, Head of EuroQuity at Bpifrance, and Natasa Kurucki, Policy Officer, DG Research and Innovation, European Commission!